Stoke Therapeutics (STOK) Shares Outstanding (Entity) (2018 - 2026)
Powered by 
Analysis
Stoke Therapeutics (STOK) Shares Outstanding (Entity) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 399.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 214.24 Mn |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 113.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 575.00 Mn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 218.28 Mn |
| 10 | Stoke Therapeutics | 1.95 Bn | 1.66 Bn | - | 62.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 62.40 Mn |
| Mar 31, 2026 | 62.24 Mn |
| Dec 31, 2025 | 58.92 Mn |
| Sep 30, 2025 | 55.12 Mn |
| Jun 30, 2025 | 54.72 Mn |
| Mar 31, 2025 | 54.60 Mn |
| Dec 31, 2024 | 54.03 Mn |
| Sep 30, 2024 | 52.94 Mn |
| Jun 30, 2024 | 52.31 Mn |
| Mar 31, 2024 | 46.50 Mn |
| Dec 31, 2023 | 45.92 Mn |
| Sep 30, 2023 | 44.29 Mn |
| Jun 30, 2023 | 44.20 Mn |
| Mar 31, 2023 | 44.18 Mn |
| Dec 31, 2022 | 39.44 Mn |
| Sep 30, 2022 | 39.43 Mn |
| Jun 30, 2022 | 39.38 Mn |
| Mar 31, 2022 | 39.04 Mn |
| Dec 31, 2021 | 36.90 Mn |
| Sep 30, 2021 | 36.78 Mn |